Keba Biological (Jiangsu) Co.
Latest round
- Series B
Last raised
- Dec 2021
Total raised
- $30M
Investors
- 4
About Keba Biological (Jiangsu) Co.
, dba SparX Group is a biotech firm that develops innovative anticancer biologics through bispecific antibodies and drug conjugates. Dr. Gui-Dong Zhu is the president and CEO of the company., Ltd. The company develops anticancer biologics utilizing the company's integrated platform for bispecific antibodies and antibody-drug conjugates. The firm provides an integrated multi-component SAILING™ antibody discovery platform combined with a sophisticated AI-based target mining algorithm, which yields multiple IND-ready drug candidates. The organization focuses on process development and commercial production.
Who invested in Keba Biological (Jiangsu) Co.
4 investors across 1 round
See all investors in Keba Biological (Jiangsu) Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Dec 31, 2021
Amount
$30M
Investors
Questions about Keba Biological (Jiangsu) Co.
Who invested in Keba Biological (Jiangsu) Co.?
Keba Biological (Jiangsu) Co. has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Keba Biological (Jiangsu) Co. raised?
Keba Biological (Jiangsu) Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Keba Biological (Jiangsu) Co. last raise money?
Keba Biological (Jiangsu) Co.'s most recent round on record is a Series B, in Dec 2021.
What does Keba Biological (Jiangsu) Co. do?
, dba SparX Group is a biotech firm that develops innovative anticancer biologics through bispecific antibodies and drug conjugates.
Where is Keba Biological (Jiangsu) Co. headquartered?
Keba Biological (Jiangsu) Co. is headquartered in Grand Cayman, Cayman Islands.
Which VCs invest in companies like Keba Biological (Jiangsu) Co.?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Keba Biological (Jiangsu) Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Keba Biological (Jiangsu) Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.